Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1198-1206

  Sampaio, Marcelo Santos ^a,b   Kuo, Hung Tien ^a,c   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS DISEASE; PANCREAS INSUFFICIENCY; POSTOPERATIVE COMPLICATION; RENAL GRAFT DYSFUNCTION; RISK ASSESSMENT; RISK FACTOR;

ADULT; COMORBIDITY; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 79957847641     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06860810     Document Type: Article

References (34)

1. Lipshutz GS, Wilkinson AH: Pancreas-kidney and pancreas transplantation for the treatment of diabetes mellitus. Endocrinol Metab Clin North Am 36: 1015-1038; x, 2007
2. Milde FK, Hart LK, Zehr PS: Pancreatic transplantation. Impact on the quality of life of diabetic renal transplant recipients. Diabetes Care 18: 93-95, 1995
3. Sureshkumar KK, Patel BM, Markatos A, Nghiem DD, Marcus RJ: Quality of life after organ transplantation in type 1 diabetics with end-stage renal disease. Clin Transplant 20: 19-25, 2006
4. Dean PG, Kudva YC, Stegall MD: Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant 13: 85-90, 2008
5. Gremizzi C, Vergani A, Paloschi V, Secchi A: Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 15: 119-123, 2010
6. Fioretto P, Sutherland DE, Najafian B, Mauer M: Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int 69: 907-912, 2006
7. Mohan P, Safi K, Little DM, Donohoe J, Conlon P, Walshe JJ, O'Kelly P, Thompson CJ, Hickey DP: Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 90: 1137-1141, 2003
8. Morath C, Zeier M, Dohler B, Schmidt J, Nawroth PP, Opelz G: Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol 19:1557-1563, 2008
9. Salvalaggio PR, Dzebisashvili N, Pinsky B, Schnitzler MA, Burroughs TE, Graff R, Axelrod DA, Brennan DC, Lentine KL: Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care 32: 600-602, 2009
10. Young BY, Gill J, Huang E, Takemoto SK, Anastasi B, Shah T, Bunnapradist S: Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: An analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol 4: 845-852, 2009
11. Gruessner AC, Sutherland DE: Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 19: 433-455, 2005
12. Light JA, Barhyte DY: Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease: Similar 10-year outcomes. Transplant Proc 37: 1283-1284, 2005
13. Light JA, Sasaki TM, Currier CB, Barhyte DY: Successful longterm kidney-pancreas transplants regardless of C-peptide status or race. Transplantation 71: 152-154, 2001
14. Sasaki TM, Gray RS, Ratner RE, Currier C, Aquino A, Barhyte DY, Light JA: Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 65: 1510-1512, 1998
15. Singh RP, Rogers J, Farney AC, Hartmann EL, Reeves-Daniel A, Doares W, Ashcraft E, Adams PL, Stratta RJ: Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation? Transplant Proc 40: 510-512, 2008
16. Nath DS, Gruessner AC, Kandaswamy R, Gruessner RW, Sutherland DE, Humar A: Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant 19: 792-797, 2005
17. Decker E, Coimbra C, Weekers L, Detry O, Honore P, Squifflet JP, Meurisse M, De Roover A: A retrospective monocenter review of simultaneous pancreas-kidney transplantation. Transplant Proc 41: 3389-3392, 2009
18. Miguel A, Garcia-Ramon R, Perez-Contreras J, Gomez-Roldan C, Alvarino J, Escobedo J, Garcia H, Lanuza M, Lopez-Menchero R, Olivares J, Tornero F, Albero D: Comorbidity and mortality in peritoneal dialysis: A comparative study of type 1 and 2 diabetes versus nondiabetic patients. Peritoneal dialysis and diabetes. Nephron 90: 290-296, 2002
19. Kervinen M, Lehto S, Ikaheimo R, Karhapaa P, Gronhagen-Riska C, Finne P: Improved survival of type 2 diabetic patients on renal replacement therapy in Finland. Nephrol Dial Transplant 25: 892-896, 2010
20. Haapio M, Helve J, Groop PH, Gronhagen-Riska C, Finne P: Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007. Diabetes Care 33: 1718-1723, 2010
21. Cavaghan MK, Ehrmann DA, Polonsky KS: Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106: 329-333, 2000
22. Grant PJ: Diabetes mellitus as a prothrombotic condition. J Intern Med 262: 157-172, 2007
23. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. JAMA 283: 221-228, 2000
24. Rosito GA, D'Agostino RB, Massaro J, Lipinska I, Mittleman MA, Sutherland P, Wilson PW, Levy D, Muller JE, Tofler GH: Association between obesity and a prothrombotic state: The Framingham Offspring Study. Thromb Haemost 91: 683-689, 2004
25. Fryirs M, Barter PJ, Rye KA: Cholesterol metabolism and pancreatic beta-cell function. Curr Opin Lipidol 20: 159-164, 2009
26. Brunham LR, Kruit JK, Hayden MR, Verchere CB: Cholesterol in beta-cell dysfunction: The emerging connection between HDL cholesterol and type 2 diabetes. Curr Diab Rep 10: 55-60, 2010
27. Young CJ, Gaston RS: Renal transplantation in black Americans. N Engl J Med 343: 1545-1552, 2000
28. Sampaio MS, Reddy PN, Kuo HT, Poommipanit N, Cho YW, Shah T, Bunnapradist S: Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant. Transplantation 89: 1117-1125, 2010
29. Lee CT, Dunn RL, Chen BT, Joshi DP, Sheffield J, Montie JE: Impact of body mass index on radical cystectomy. J Urol 172: 1281-1285, 2004
30. Williams TK, Rosato EL, Kennedy EP, Chojnacki KA, Andrel J, Hyslop T, Doria C, Sauter PK, Bloom J, Yeo CJ, Berger AC: Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 208: 210-217, 2009
31. Sener A, Cooper M, Bartlett ST: Is there a role for pancreas transplantation in type 2 diabetes mellitus? Transplantation 90: 121-123, 2010
32. Falorni A, Brozzetti A: Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 19: 119-133, 2005
33. Chakkera HA, Bodner JK, Heilman RL, Mulligan DC, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Ray RM, Beck GL, Reddy KS: Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus. Transplant Proc 42: 2650-2652, 2010
34. Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR: Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int 58: 1742-1750, 2000